Meeting
2020 ASCO Virtual Scientific Program
Contrasting genomic profiles in post-systemic treatment metastatic sites (MET), pretreatment primary tumors (PT), and liquid biopsies (LB) of clinically advanced prostate cancer (PC).
Authors
Andrea Necchi
Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Andrea Necchi , Petros Grivas , Gennady Bratslavsky , Oleg Shapiro , Joseph M Jacob , Ethan Sokol , Jonathan Keith Killian , Douglas I. Lin , Shakti H. Ramkissoon , Eric Allan Severson , Richard Huang , Brian Michael Alexander , Jeffrey Venstrom , Venkataprasanth P. Reddy , Kimberly McGregor , Julia Andrea Elvin , Alexa Betzig Schrock , Dean Pavlick , Natalie Danziger , Jeffrey S. Ross
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 38: 2020 (suppl; abstr 5534)
DOI
10.1200/JCO.2020.38.15_suppl.5534
Abstract #
5534
Poster Bd #
115
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Genomic classification of clinically advanced major genito-urinary cancers (GUca) based on methylthioadenosine phosphorylase (MTAP) genomic loss.
First Author: Philippe E. Spiess
Poster
2020 Genitourinary Cancers Symposium
Comprehensive genomic profiling (CGP) in post-systemic treatment (Post) metastatic sites (MET) and pretreatment (Pre) primary tumors (PT) of metastatic prostate cancer (mPC).
First Author: Andrea Necchi
Poster
2023 ASCO Genitourinary Cancers Symposium
Single and multi-hit PIK3CA short variant (SV) genomic alterations (GA) in clinically advanced prostate cancer (CAPC): A genomic landscape study.
First Author: Carla Miguel
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Genomic classification of clinically advanced pancreatic ductal adenocarcinoma (PDAC) based on methylthioadenosine phosphorylase (MTAP) genomic loss (MTAP loss).
First Author: Natalie Ngoi